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Abstract 
We have studied a new approach for the resolution and absolute configuration 
determination of the enantiomers of squalene diols as intermediate precursors in the 
chemical synthesis of different squalene oxides (SOs); (3R)- and (3S)-2,3-SO, (6R,7R)- 
and (6S,7S)-6,7-SO, and (10R,11R)- and (10S,11S)-10,11-SO. Monoderivatization of 
the corresponding racemic squalene diol intermediates with pure stereoisomers of (S)-
(+)-methoxyphenyl acetic acid ((S)-(+)-MPA), (S)-(+)-9-anthrylmethoxyacetic acid 
((S)-(+)-9-AMA) and (S)-(+)-acetoxyphenylacetic acid ((S)-(+)-APA) afforded the 
diastereomeric esters which could be easily separated by column flash chromatography 
with silica gel. In addition, the absolute configuration for these diastereoisomers of the 
derivatized diols was advantageously inferred from 1H NMR data according to the 
models depicted for these derivatizing chiral agents. In order to demonstrate the 
absolute configuration assignment of the different stereoisomers, (S)-(+)-AMA showed 
the larger @A by 1H NMR, however, (S)-(+)-MPA esters were much more stable 
derivatives. 
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Introduction 
In the past years, we developed a route to synthesize and determine the absolute 
configuration of the different enantiomers of the squalene oxides using 2,3- and erythro-
6,7- and 10,11-squalene diols (Sdiols) as intermediates. In this case, the resolution of 
the corresponding Sdiols was achieved by derivatization with MTPA (Mosher´s acid, D-
methoxy-D-trifluoromethylphenylacetic acid). In addition, we demonstrated that these 
enantiomers of the internal SOs were valuable substrates for inhibitory studies of 
Squalene Epoxidase (SE) leading to the epoxidation at both terminal double bonds of 
the squalene chain but affording regioselective and asymmetric ratios of enantiomers of 
squalene dioxides.1 Likewise, we studied the activity and interactions of the resulting 
squalene dioxides with oxidosqualene-lanosterol cyclase (OSLC), another key enzyme 
in the cholesterol biosynthesis.1
In this paper we report a practical new approach to resolve both enantiomers of the 
different squalene diols with high enantiomeric excesses by simple flash 
chromatography using as derivatizing agents chiral aryl acetic acids currently applied to 
determine the absolute configuration of secondary alcohols. For this purpose, the (S)-
(+)-MPA, (S)-(+)-APA, and (S)-(+)-9-AMA diastereomeric esters from the above 
squalene diols were prepared (Fig. 1) and separated by flash chromatography with silica 
gel. In addition, we present here the 1H NMR data needed for the easy assignment of the 
absolute configuration of the derivatized secondary carbinols present in 2,3- and 
erythro-squalene diols and we compare these results with the more cumbersome 
assignation from data previously obtained for the above squalene diols derivatized with 
MTPA.1
Insert Figure 1 
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Results and Discussion 
Preparation, derivatization and separation of the 2,3- and erythro-squalene diols. 
So far, there have been a great number of studies for the synthesis of chiral squalene 
epoxides. In most of these syntheses, 2,3-squalene diols were used as versatile key 
intermediates in the preparation of enantiomerally pure 2,3-squalene oxides. Other 
approaches were reported by using chiral synthons,2 by enantioselective reactions3 or by 
chemical resolution of the diols.1,4 among others. Previously, we had performed the 
chemical resolution strategy involving the formation of the (R)-MTPA esters of the 
corresponding enantiomers of 2,3-, erythro-6,7- and erythro-10,11-squalene diols. The 
obtained esters were submitted to HPLC chromatographic resolution and used for 
further determination of the absolute configuration of the stereogenic centers present at 
the squalene skeleton for each diastereoisomer. But HPLC chromatographic resolution 
by reverse phase HPLC was very tedious and difficult. 
Our ongoing interest in resolving secondary alcohols with lipases5 has led us to 
undertake the search for a new enzymatic strategy. In this context, specific lipases could 
be able to remove selectively the arylacetic group from the derivatized diasteromeric 
(S)-(+)-esters of the corresponding squalene diols. As a result, we would be able to 
separate both enantiomers of the racemic mixture facilitating the stereochemical studies 
of the resolved diol intermediate and determining the absolute configuration of both 
diasteromeric esters. Consequently, we decided to prove this strategy for arylacetic 
derivatized compounds which could be potential substrates with acylases or lipases and 
had been utilized in determining the absolute configuration of secondary alcohols, such 
as (S)-(+)-MPA, (S)-(+)-APA, and (S)-(+)-9-AMA esters. In this context, some 
representative model secondary alcohols were derivatized and enzymatically hydrolized 
but results were not so good as anticipated and this approach was disregarded. 
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2,3-Squalene diol, erythro-6,7- and erythro-10,11-squalene diol were prepared 
according to procedures previously reported1 and derivatization with (S)-(+)-MPA, (S)-
(+)-APA, and (S)-(+)-9-AMA, was achieved by one of these two methods: (1) By 
previous preparation of the proper acid chloride and then reaction with the squalene diol 
in presence of DMAP and NEt36 or (2) by using a carbodiimide in presence of DMAP.5
Apparently, no important racemizations have been reported under the derivatization 
conditions described for these two methods and yields used to be higher than 90%.  
Surprisingly, when we analyzed the reaction mixture by TLC we observed high 
differences of Rf in the TLC plate for all the squalene arylacetic esters prepared. As an 
example, TLC separation of diasteromeric esters was better for the derivatizing acid in 
the order 9-AMA> APAK MPA and for the derivatized diol in the order 10,11- > 6,7- > 
2,3-squalene diol. As we expected, stability of products followed the order MPA >> 
APA > 9-AMA, since after 1 year of storage only 4% of MPA derivatized product was 
isomerized. 1H, 13C NMR and HPLC-MS-FIA data allowed us to determine that the two 
major products formed corresponded to the monoderivatized diastereoismers at the 
secondary carbinol of the squalene diol. 
Absolute configuration determination of the 2,3-, erythro-6,7- and erythro-10,11-
squalene diols. Since Mosher7 proposed 1H NMR to determine the absolute 
configuration of stereogenic centers of secondary alcohols derivatized with MTPA, 
many other researchers have reported similar methodologies and derivatizing agents. 
Most of these methodologies try to visualize important 1H NMR chemical shifts 
changes due to the diamagnetic effect of the aromatic ring(s) on certain protons of the 
derivatized molecule. Obviously, the success to determine the absolute configuration of 
a derivatized alcohol by 1H NMR depends on the  value calculated from the different 
chemical shifts for the same hydrogen of both diastereoisomers. The greater is this 
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anisotropy effect in both diastereomers, the easier is the proton chemical shifts 
differentiation and therefore the absolute configuration determination. When we applied 
this technique to determine the absolute configuration of the squalene diols derivatized 
with (R)-MTPA by NMR, the chemical shifts signals of the diasteromeric derivatives 
were too close with only small  values among 0.15-0.05 ppm, complicating the 
assignment process. However, the recent availability of acids like MPA, APA and 9-
AMA has facilitated the application of the corresponding stereochemical models for the 
assignment of absolute configurations. In order to extend the use of this methodology, 
we present here a comparative study of the  values obtained for the assignment of the 
absolute configuration of the squalene diols and we compare these results with the 
previously studied derivatives obtained with Mosher’s acid (MTPA). 
To this aim, 1H, 13C NMR, DQFCOSY and XH-CORFE spectra for the different 
arylacetic esters were registered, and interpretation of COSY and HETCOR data 
allowed the assignments of 1H and 13C NMR signals, which readily demonstrated that 
another difference between them was the asymmetric diamagnetic effect of the aromatic 
ring(s) on the 1H NMR chemical shifts for the hydrogens with respect to each 
diastereoisomer. 
The 1H and 13C NMR chemical shift increments (A) in each pair of diastereomeric 
esters are shown in Schemes 1, 2 and 3. 1H NMR A calculations showed a similar sign 
behavior for the squalene diols substituents in all arylacetic esters. As we had checked 
previously for aliphatic chains, hydrogens at  position from the carbinol exhibited the 
highest shielding effect.8 As expected, (S)-(+)-9-AMA showed the most important 
shielding values for both diastereomeric esters (i.e., 1 ppm for hydrogens at  position). 
However, results using APA were comparable to those obtained with MPA (i.e., 0.4 
ppm for hydrogens at  position), but much better than those reported with MTPA (i.e, 
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0.15 ppm for hydrogens at  position). Likewise, 13C NMR chemical shift assignments 
showed a 13C NMR A behavior similar to that observed for 1H NMR 9 and the highest 
anisotropy effect was observed for the carbons located at  position from the carbinol 
substitution. (cf Schemes 1, 2 and 3). 
Insert Schemes 1, 2 and 3 
Comparison with the corresponding stereochemical models for (S)-(+)-MPA,10 (S)-(+)-
APA,11 and (S)-(+)-9-AMA12 allowed us to determine the absolute configuration of the 
stereocenter of each diastereoisomer in the derivatized carbinol resulting in the “S”
configuration for the less polar diastereoisomer (c.a Rf 0.4, hexane:MTBE 7:3). 
Reduction or saponification of individual isomers of Sdiols esters with LiAlH4 /Diethyl 
Ether or K2CO3 in MeOH, respectively, gave rise to the enantiomeric diols. As 
expected, sign of the optical rotation of the released squalene diol confirmed the 
absolute configuration assignment. Since resolution has been so good, we expected that 
the optical purity of the enantiomerically pure squalene diols were in agreement with 
the enantiomeric purity of the ester precursors. However, rederivatization with (S)-(+)-
MPA of each one of the resulting squalene diols and TLC and HPLC analysis of the 
resulting esters showed that there was 6-8% of isomerized alcohol. This isomerization 
was much more important (up to 12%) for squalene diols previously derivatized with 
(S)-(+)-APA and by the acyl chloride method. These results are somewhat worse than 
those observed for the derivatized squalene diols obtained after rederivatization with 
MTPA that showed 5% of isomerization. In spite of the higher degree of isomerization, 
any of the recovered enantiomerically enriched squalene diols could be useful as 
squalene oxides intermediates to perform any biological experiment.  
In conclusion, we have improved the methodology for the separation and absolute 
configuration determination of the different squalenediol stereoisomers that afford the 
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biologically active squalene oxides. In this context, MPA esters of squalene diols are the 
most appropriate and stable derivatized intermediates to separate and determine the 
absolute configuration of the enantiomers of the squalene diols. 
Experimental Section 
General Methods. The liquid chromatography-mass spectrometry analyses (HPLC-
MS-FIA) were performed with an apparatus with a chemical ionization interface at 
atmospheric pressure and diode array detector (CH3CN/H2O (80:20) at 1 mL/min; 
positive mode). All 1H NMR spectra were acquired at 300 MHz, and 13C NMR spectra, 
at 75 MHz in freshly neutralized CDCl3 solutions, and chemical shifts are given in ppm 
using as internal standards Si(CH3)4 for 1H, and CDCl3 for 13C. The standard 1H
DQFCOSY and XH-CORFE spectra for the determination of the absolute configuration 
of (S)-(+)-9-AMA, (S)-(+)-MPA and (S)-(+)-APA esters were recorded at 25 ºC using 
the same concentration for both diastereomeric pairs as described elsewhere. 1 All IR 
spectra were run as film. 
Unless otherwise stated, organic solutions obtained from workup of crude reaction 
mixtures were dried over MgSO4. The purification procedures were carried out by flash 
chromatography on silica gel (230-400 mesh) and products were obtained as oils unless 
otherwise specified. Visualization of UV-inactive materials was accomplished by 
soaking the TLC plates in an ethanolic solution of anisaldehyde and sulfuric acid (v/v/v, 
96:2:2). Optical rotations were determined at 25º in CHCl3 solution at the specified 
concentration (g/100 mL). Enantiomeric and diastereomeric excesses (ee and de) values 
of the corresponding (S)-(+)-arylacetic diastereomeric esters were calculated by NMR 
or by HPLC analyses using Spherisorb ODS-2 (5 µm) columns (10 x 0.6 cm and 15 x 1 
cm, respectively) and eluting with CH3CN-H2O mixtures at 1 mL/min. All TLC plates 
were eluted with hexanes:MTBE 7:3. 
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Preparation of esters from the acid chloride. General Procedure 
Oxalyl chloride (370 µL, 4.2 mmol) was added to a mixture of the corresponding acid 
[(S)-(+)-APA, -MPA, -9-AMA] (0.7 mmol) and DMF (10 µL, 0.12 mmol) in 30 mL of 
hexane at room temperature. After 2 days, solvent was evaporated to dryness at reduced 
pressure to afford the acid chloride. The freshly prepared acid chloride [APA-Cl, MPA-
Cl, 9-AMA-Cl] was dissolved in 4 mL of CH2Cl2 and added to a solution of the 
squalene diol (250 mg, 0.56 mmol), Et3N (240 µL, 1.7 mmol) and DMAP (60 mg, 0.55 
mmol) in 20 mL of CH2Cl2. After 30 min, water was added (10 mL), decanted and the 
organic solution was dried, concentrated at reduced pressure to a residue which was 
purified by flash chromatography on silica gel using a gradient of 0-30% MTBE 
(methyl tert-butyl ether) in hexane (83-89% yield). 
Preparation of esters by the carbodiimide methodology. General Procedure 
A mixture of DMAP (0.2 mmol), arylacetic acid (0.32 mmol), N-(3-
dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (0.3 mmol) and squalene 
diol (0.2 mmol) in 2 mL of CH2Cl2 was stirred for 1 h at RT, washed with NaHCO3
solution, concentrated at reduced pressure and purified by flash chromatography on 
silica gel using a gradient of 0-30% MTBE in hexane (85-92% yield). 
(S)-(+)--methoxy--(9-anthryl)-acetate of (3S)-2,3-Squalenediol (higher Rf in 
TLC). Rf=0.22; IR 3450, 2965, 2925, 2855, 1750 (CO), 1450, 1380, 1190, 1115, 730 
cm -1; 1H NMR  8.61(d, J = 8 Hz, 2H), 8.47 (s, 1H), 8.02 (dd, J1 = 8 Hz, J2 = 1 Hz, 
2H), 7.60-7.40 (4H), 6.33 (s, 1H), 5.20-5.00 (5H), 4.73 (dd, J1 = 10 Hz, J2 = 2.5 Hz, 
1H), 3.46 (s, 3H), 2.20-1.92 (18H), 1.68 (s, 3H), 1.60 (bs, 12H), 1.58 (s, 3H), 1.60-1.20 
(4H), 0.58 (s, 1H), 0.46 (s,3H), 0.41 (s, 3H); 13C NMR  170.7,135.1, 135.0, 134.9, 
133.9, 131.3, 131.2, 130.4, 129.3, 129.2, 127.1, 126.8, 125.1, 124.9, 124.4, 124.3, 
124.2, 80.8, 77.2, 71.8, 57.4, 39.7, 39.7, 39.7, 36.0, 28.3, 27.9, 26.7, 26.6, 25.7, 25.3, 
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23.9, 17.7, 16.0, 16.0; HPLC-MS-FIA m/z 710 (M·++18), 692 (M·+), 677 (M·+–18+3), 
427 (M·+-265); []D= +43.4 (c=1, 98% de). 
(S)-(+)--methoxy--(9-anthryl)-acetate of (3R)-2,3-Squalenediol (lower Rf in 
TLC). Rf=0.08; IR 3450, 2965, 2925, 2855, 1750 (CO), 1450, 1380, 1190, 1115, 730 
cm -1; 1H NMR  8.61(d, J = 8 Hz, 2H), 8.47 (s, 1H), 8.02 (d, J = 8 Hz, 2H), 7.60-7.40 
(4H), 6.35 (s, 1H), 5.20-5.00 (4H), 4.73 (dd, J1 = 10 Hz, J2 = 2 Hz, 1H), 4.23 (m, 1H), 
3.44 (s, 3H), 2.14-1.92 (12H), 1.79 (s, 1H), 1.78 (s, 3H), 1.68 (d, J = 1 Hz, 3H), 1.60 
(bs, 9H), 1.54 (d, J = 1 Hz, 3H), 1.32 (m, 2H), 1.11 (s,3H), 1.06 (s,3H), 0.98 (d, J = 1
Hz, 3H), 1.10-0.7 (2H); 13C NMR  171.4,135.1, 134.9, 133.3, 131.5, 131.2, 130.5, 
129.2, 129.2, 127.1, 126.6, 125.0, 124.4, 124.4, 124.4, 124.2, 124.1, 80.6, 77.3, 72.5, 
57.4, 39.7, 39.7, 39.5, 34.8, 28.2, 27.9, 26.7, 26.6, 26.6, 25.7, 24.2, 17.7, 16.0, 15.2; 
HPLC-MS-FIA m/z 710 (M·+ +18), 691 (M·+-1), 677 (M·+–18+3), 427 (M·+-265); []D=
+77.6 (c=1, 98% de). 
(S)-(+)--methoxy--(9-anthryl)-acetate of (6R,7S)-6,7-Squalenediol (higher Rf in 
TLC). Rf=0.47; IR 3450, 2965, 2925, 2855, 1750 (CO), 1450, 1380, 1190, 1115, 730 
cm -1; 1H NMR  8.59(bb, 2H), 8.47 (s, 1H), 8.01 (d, J = 8 Hz, 2H), 7.62-7.42 (4H), 
6.32 (s, 1H), 5.22-5.02 (4H), 4.76 (dd, J1 = 10 Hz, J2 = 2.5 Hz, 1H), 4.23 (t, J = 10 Hz, 
1H), 3.46 (s, 3H), 2.16-1.90 (12H), 1.68 (d, J = 1 Hz, 3H), 1.62 (d, J = 1 Hz, 3H), 1.60 
(bs, 12H), 1.59 (s, 3H), 1.56 (s, 3H), 1.60-1.10 (3H), 1.37 (s, 3H), 0.87 (m, 1H), 0.63 
(m,1H), 0.45 (m, 1H), 0.39 (s, 3H); 13C NMR  170.6,135.2, 134.8, 134.1, 131.3,
131.3, 131.2, 130.4, 129.3, 129.2, 127.1, 126.7, 125.1, 124.8, 124.3, 124.2, 124.1, 
123.9, 80.1, 77.2, 73.5, 57.3, 39.7, 39.7, 36.5, 36.2, 28.3, 28.2, 27.5, 26.7, 26.6, 25.6, 
25.5, 22.1, 21.2, 17.6, 17.4, 16.0, 16.0, 16.0; HPLC-MS-FIA m/z 710 (M·++18), 692 
(M·+), 675 (M·+–18+1), 427 (M·+-265); []D= +43.4 (c=1, 98% de). 
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(S)-(+)--methoxy--(9-anthryl)-acetate of (6S,7R)-6,7-Squalenediol (lower Rf in 
TLC). Rf=0.15; IR 3450, 2965, 2925, 2855, 1750 (CO), 1450, 1375, 1190, 1115, 730 
cm -1; 1H NMR  8.59(bb, 2H), 8.47 (s, 1H), 8.01 (d, J = 8 Hz, 2H), 7.60-7.40 (4H), 
6.35 (s, 1H), 5.18-4.98 (4H), 4.78 (dd, J1 = 10 Hz, J2 = 2 Hz, 1H), 4.28 (t, J = 6.5 Hz, 
1H), 3.43 (s, 3H), 2.16-1.90 (10H), 1.90-1.64 (4H), 1.68 (s, 6H), 1.59 (s, 6H), 1.56 (s, 
3H), 1.60-1.08 (6H), 1.05 (s, 3H), 0.98 (s, 3H), 0.84 (m, 2H); 13C NMR  171.2,134.9,
134.8, 133.6, 131.9, 131.4, 131.2, 130.5, 129.2, 129.1, 127.1, 126.5, 125.0, 124.3, 
124.3, 124.2, 80.1, 77.3, 74.0, 57.4, 39.7 37.2, 34.9, 28.0, 28.0, 27.7, 26.7, 26.6, 25.7, 
23.7, 21.9, 17.6, 17.6, 16.0, 15.2; HPLC-MS-FIA m/z 710 (M·++18), 692 (M·+), 675 
(M·+–18+1), 427 (M·+ - 265); []D= +50.8 (c=1, 98% de). 
(S)-(+)--methoxy--(9-anthryl)-acetate of (10R,11S)-10,11-Squalenediol (higher 
Rf in TLC). Rf=0.48; IR 3530, 2975, 2935, 2860, 1750 (CO), 1445, 1380, 1180, 1110, 
725 cm -1; 1H NMR  8.62 (bb, 2H), 8.47 (s, 1H), 8.01 (d, J = 8 Hz, 2H), 7.62-7.42 
(4H), 6.32 (s, 1H), 5.20-5.00 (4H), 4.79 (dd, J1 = 10 Hz, J2 = 2 Hz, 1H), 4.48 (t, J = 7
Hz, 1H), 3.46 (s, 3H), 2.16-1.90 (12H), 1.85 (m, 2H), 1.68 (s, 6H), 1.62 (s, 3H), 1.60 
(bs, 9H), 1.70-1.10 (4H), 1.37 (s, 3H), 0.66 (s, 1H), 0.64 (m, 1H), 0.43 (m,1H), 0.39 (s, 
3H); 13C NMR  170.6,136.0, 135.0, 131.3, 131.3, 131.2, 130.4, 129.3, 129.2, 127.1, 
126.7, 125.1, 124.3, 124.2, 124.1, 123.8, 123.3, 80.0, 77.1, 73.5, 57.4, 39.7, 39.7, 39.6, 
36.4, 29.4, 26.7, 26.6, 26.6, 25.7, 24.7, 22.2, 21.1, 17.7, 16.1, 16.0, 15.7; HPLC-MS-
FIA m/z 710 (M·++18), 692 (M·+), 675 (M·+–18+1), 427 (M·+-265); []D= +41.1 (c=1, 
98% de). 
(S)-(+)--methoxy--(9-anthryl)-acetate of (10S,11R)-10,11-Squalenediol (lower Rf 
in TLC). Rf=0.20; IR 3530, 2975, 2935, 2855, 1745 (CO), 1445, 1380, 1180, 1110, 725 
cm -1; 1H NMR  8.60 (bb, 2H), 8.46 (s, 1H), 8.00 (d, J = 8 Hz, 2H), 7.60-7.40 (4H), 
6.34 (s, 1H), 5.16-4.92 (4H), 4.85 (dd, J1 = 10 Hz, J2 = 2 Hz, 1H), 4.59 (t, J = 7 Hz, 
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1H), 3.42 (s, 3H), 2.14-1.85 (12H), 1.74 (m, 2H), 1.68 (d, J = 1 Hz, 3H), 1.66 (d, J = 1
Hz, 3H), 1.61 (s, 3H), 1.58 (bs, 6H), 1.54 (d, J = 1 Hz, 3H), 1.70-1.10 (6H), 1.06 (s, 
3H), 0.88 (s, 3H), 1.10-0.80 (2H); 13C NMR  171.3,135.5, 135.5, 134.8, 131.4, 131.4,
130.8, 130.5, 129.2, 129.1, 127.1, 126.5, 125.0, 124.3, 124.2, 124.1, 124.0, 122.7, 80.3, 
77.4, 74.1, 57.4, 39.7, 39.4, 37.1, 29.2, 26.7, 26.6, 26.4, 25.7, 23.8, 23.6, 21.8, 17.7, 
17.6, 15.9, 15.9, 15.3; HPLC-MS-FIA m/z 710 (M·++18), 692 (M·+), 675 (M·+–18+1), 
427 (M·+-265); []D= +57.4 (c=1, 98% de). 
(S)-(+)--methoxy--(phenyl)-acetate of (3S)-2,3-Squalenediol (higher Rf). 
Rf=0.22; IR 3510, 2965, 2925, 2855, 1750 (CO), 1455, 1380, 1190, 1115, 730 cm -1; 1H
NMR  7.52-7.42 (2H), 7.30–7.42 (3H), 5.22-5.00 (5H), 4.80 (s, 1H), 4.79 (dd, J1 = 10
Hz, J2 = 3 Hz, 1H), 3.44 (s, 3H), 2.14-1.86 (18H), 1.68 (d, J = 1 Hz, 3H), 1.60 (bs, 
12H), 1.56 (d, J = 1 Hz, 3H), 1.60-1.20 (5H), 0.94 (s, 3H), 0.91 (s, 3H); 13C NMR 
 170.4,136.5, 135.1, 135.0, 134.9, 133.8, 131.2, 129.0, 128.7, 127.2, 125.0, 124.4, 
124.3, 124.2, 82.6, 80.5, 72.3, 57.3, 39.7, 39.7, 39.6, 35.9, 28.3, 28.0, 26.7, 26.7, 26.6, 
25.9, 25.7, 24.6, 17.7, 16.0, 16.0; HPLC-MS-FIA m/z 610 (M·++18), 593 (M·++1), 575 
(M·+–18+1), 427 (M·+-165); []D= +25.0 (c=1, 98% de). 
(S)-(+)--methoxy--(phenyl)-acetate of (3R)-2,3-Squalenediol (lower Rf in TLC). 
Rf=0.15;  IR 3510, 2965, 2925, 2855, 1750 (CO), 1455, 1380, 1190, 1115, 730 cm -1;
1H NMR  7.52-7.42 (2H), 7.30–7.42 (3H), 5.20-5.05 (4H), 4.81 (s, 1H), 4.78 (dd, J1 =
10 Hz, J2 = 2.5 Hz, 1H), 4.76 (t, J = 6 Hz, 1H), 3.44 (s, 3H), 2.14-1.86 (18H), 1.68 (d, J
= 1 Hz, 3H), 1.60 (bs, 9H), 1.58 (d, J = 1 Hz, 3H), 1.60-1.20 (5H), 1.38 (d, J = 1 Hz, 
3H), 1.16 (s, 3H), 1.16 (s, 3H); 13C NMR  170.8,136.3, 135.1, 135.0, 134.9, 133.5, 
131.2, 128.8, 128.6, 127.1, 124.9, 124.4, 124.2, 82.7, 80.3, 72.4, 57.3, 39.7, 39.7, 39.6, 
35.3, 28.2, 28.1, 26.7, 26.6, 25.7, 24.7, 17.6, 16.0, 16.0, 15.7; HPLC-MS-FIA m/z 610 
(M·++18), 593 (M·++1), 575 (M·+–18 + 1), 427 (M·+-165); []D= +28.8 (c=1, 98% de). 
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(S)-(+)--methoxy--(phenyl)-acetate of (6R,7S)-6,7-Squalenediol (higher Rf in 
TLC). Rf=0.30; IR 3525, 2965, 2925, 2855, 1750 (CO), 1455, 1375, 1200, 1175, 1115, 
1000, 730, 695 cm -1; 1H NMR  7.52-7.42 (2H), 7.30–7.42 (3H), 5.20-5.02 (4H), 4.94 
(m, 1H), 4.83 (dd, J1 = 10 Hz, J2 = 3 Hz, 1H), 4.78 (s, 3H), 3.43 (s, 3H), 2.14-1.80 
(18H), 1.80-1.54 (4H), 1.68 (d, J = 1 Hz, 3H), 1.66 (d, J = 1 Hz, 3H), 1.60 (bs, 9H), 
1.56 (bs, 6H), 1.26 (s, 1H), 1.18 (m, 2H), 0.87 (s, 3H); 13C NMR  170.3,136.5, 135.2, 
134.9, 134.1, 131.9, 131.3, 128.9, 128.7, 127.2, 124.9, 124.4, 124.2, 124.2, 124.1, 82.6, 
79.8, 74.0, 57.2, 39.7, 39.7, 37.1, 36.0, 28.3, 28.2, 27.6, 26.7, 26.7, 25.7, 22.9, 21.8, 
17.7, 17.6, 16.0, 16.0; HPLC-MS-FIA m/z 610 (M·++18), 593 (M·++1), 575 (M·+–18+1), 
427 (M·+-165); []D= +21.2 (c=1, 98% de). 
(S)-(+)--methoxy--(phenyl)-acetate of (6S,7R)-6,7-Squalenediol (lower Rf in 
TLC). Rf=0.25; IR 3505, 2965, 2925, 2855, 1750 (CO), 1455, 1375, 1200, 1175, 1115, 
1000, 730, 695 cm -1; 1H NMR  7.52-7.42 (2H), 7.30–7.42 (3H), 5.20-5.02 (4H), 4.82 
(dd, J1 = 10 Hz, J2 = 3 Hz, 1H), 4.80 (s, 3H), 4.81 (m, 1H), 3.43 (s, 3H), 2.14-1.80 
(18H), 1.78-1.30 (5H), 1.68 (bs, 6H), 1.62 (d, J = 1 Hz, 3H), 1.60 (bs, 9H), 1.37 (d, J =
1 Hz, 3H), 1.12 (s, 3H); 13C NMR  170.7,136.3, 135.0, 134.9, 133.8, 132.0, 131.2,
128.8, 128.6, 127.1, 124.8, 124.4, 124.2, 124.2, 82.7, 79.8, 74.0, 57.3, 39.7, 39.7, 37.4, 
35.4, 28.2, 28.1, 27.8, 26.7, 26.6, 25.7, 23.5, 22.0, 17.6, 16.0, 16.0, 15.7; HPLC-MS-
FIA m/z 610 (M·++18), 593 (M·++1), 575 (M·+–18+1), 427 (M·+-265); []D= +26.0 (c=1, 
98% de). 
(S)-(+)--methoxy--(phenyl)-acetate of (10R,11S)-10,11-Squalenediol (higher Rf 
in TLC). Rf=0.35; IR 3520, 2965, 2925, 2855, 1750 (CO), 1455, 1375, 1200, 1175, 
1115, 1000, 730, 695 cm -1; 1H NMR  7.52-7.42 (2H), 7.42–7.28 (3H), 5.18-5.02 (4H), 
4.95 (m, 1H), 4.86 (dd, J1 = 9.5 Hz, J2 = 3.5 Hz, 1H), 4.78 (s, 1H), 3.43 (s, 3H), 2.14-
1.80 (18H), 1.80-1.60 (2H), 1.68 (bs, 6H), 1.60 (bs, 9H), 1.56 (bs, 6H), 1.27 (s, 1H), 
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1.18 (m, 2H), 0.87 (s, 3H); 13C NMR  170.3,136.5, 136.0, 135.5, 135.0, 131.4, 131.2, 
128.9, 128.7, 127.3, 124.3, 124.2, 124.1, 124.0, 82.6, 79.8, 74.0, 57.3, 39.7, 39.7, 37.1, 
29.3, 26.7, 26.6, 25.7, 24.6, 22.8, 21.7, 17.7, 16.0, 16.0, 15.9; HPLC-MS-FIA m/z 610 
(M·++ 18), 593 (M·++ 1), 575 (M·+–18 +1), 427 (M·+-265);  []D= +27.0 (c=1, 98% de). 
(S)-(+)--methoxy--(phenyl)-acetate of (10S,11R)-10,11-Squalenediol (Lower Rf 
in TLC). Rf=0.27; IR 3520, 2965, 2925, 2855, 1750 (CO), 1455, 1375, 1200, 1175, 
1115, 1000, 730, 695 cm -1; 1H NMR  7.52-7.42 (2H), 7.40–7.28 (3H), 5.18-5.02 (4H), 
4.92 (m, 1H), 4.86 (ca, 1H), 4.81 (s, 1H), 3.44 (s, 3H), 2.16-1.80 (18H), 1.80-1.30 (5H), 
1.68 (bs, 6H), 1.60 (bs, 9H), 1.58 (d, J = 1 Hz, 3H), 1.33 (d, J = 1 Hz, 3H), 1.26 (s, 1H), 
1.11 (s, 3H); 13C NMR  170.7,136.3, 136.0, 135.7, 134.9, 131.4, 131.2, 128.8, 128.6, 
127.0, 124.3, 124.2, 124.1, 124.0, 123.0, 82.8, 79.9, 74.1, 57.3, 39.7, 39.7, 39.6, 37.4, 
29.3, 26.7, 26.6, 26.5, 25.7, 24.1, 23.6, 21.9, 17.7, 16.0, 16.0, 15.8; HPLC-MS-FIA m/z 
610 (M·++18), 593 (M·++1), 575 (M·+–18+1), 427 (M· -265); []D= +26.6 (c=1, 98% de). 
(S)-(+)--acetoxy--(phenyl)-acetate of (3S)-2,3-Squalenediol (higher Rf in TLC). 
Rf=0.30; IR 3510, 2970, 2925, 2855, 1750 (CO), 1450, 1380, 1200, 1175, 1115, 730, 
695 cm -1; 1H NMR  7.58-7.46 (2H), 7.44–7.32 (3H), 5.93 (s, 1H), 5.24-5.02 (5H), 
4.79 (dd, J1 = 10 Hz, J2 = 2.5 Hz, 1H), 2.21 (s, 3H), 2.14-1.84 (18H), 1.68 (d, J = 1 Hz, 
3H), 1.60 (bs, 12H), 1.57 (bs, 3H), 1.60-1.20 (5H), 0.95 (s, 6H); 13C NMR  170.5,
168.6, 135.1, 135.1, 134.9, 133.9, 133.8, 131.2, 129.4, 128.8, 127.6, 125.0, 124.4, 
124.3, 124.2, 81.2, 74.8, 72.2, 39.7, 39.7, 39.6, 35.6, 28.3, 28.2, 26.7, 26.6, 25.7, 24.6, 
20.8, 17.7, 16.0, 16.0; HPLC-MS-FIA m/z 638 (M·++18), 621 (M·++1), 603 (M·+–18 + 
1), 427 (M·-193); []D= +26.0 (c=1, 98% de). 
(S)-(+)--acetoxy--(phenyl)-acetate of (3R)-2,3-Squalenediol (lower Rf in TLC). 
Rf=0.16; IR 3510, 2970, 2925, 2855, 1750 (CO), 1450, 1380, 1200, 1175, 1115, 730, 
695 cm -1; 1H NMR  7.58-7.46 (2H), 7.44–7.32 (3H), 5.86 (s, 1H), 5.22-5.02 (4H), 
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4.80 (dd, J1 = 10 Hz, J2 = 2 Hz, 1H), 4.74 (t, J = 6 Hz, 1H), 2.20 (s, 3H), 2.14-1.85 
(18H), 1.70-1.20 (5H), 1.68 (d, J = 1 Hz, 3H), 1.60 (bs, 9H), 1.58 (d, J = 1 Hz, 3H), ), 
1.36 (d, J = 1 Hz, 3H), 1.21 (s, 6H); 13C NMR  170.7,168.9, 135.1, 135.0, 134.9,
133.5, 133.4, 131.2, 129.4, 128.8, 128.8, 127.6, 124.8, 124.4, 124.2, 80.9, 75.0, 72.3, 
39.7, 39.7, 39.6, 35.2, 28.2, 28.0, 26.7, 26.6, 26.0, 25.7, 25.1, 20.7, 17.6, 16.0, 16.0, 
15.7; HPLC-MS-FIA m/z 638 (M·++18), 621 (M·++1), 603 (M·+–18+1), 427 (M·-193); 
[]D= +27.4 (c=1, 98% de). 
(S)-(+)--acetoxy--(phenyl)-acetate of (6R,7S)-6,7-Squalenediol (higher Rf in 
TLC). Rf=0.40; IR 3520, 2965, 2925, 2855, 1750 (CO), 1455, 1375, 1230, 1175, 1055, 
740, 695 cm -1; 1H NMR  7.56-7.44 (2H), 7.43–7.35 (3H), 5.91 (s, 1H), 5.20-5.05 
(5H), 4.94 (m, 1H), 4.84 (dd, J1 = 10 Hz, J2 = 2.5 Hz, 1H), 2.21 (s, 3H), 2.14-1.80 
(18H), 1.68 (d, J = 1 Hz, 3H), 1.66 (d, J = 1 Hz, 3H), 1.60 (bs, 9H), 1.60-1.20 (2H), 
1.57 (bs, 6H), 1.40 (s, 1H), 1.28-1.13 (3H), 0.91 (s, 3H); 13C NMR  170.5,168.5, 
135.1, 134.9, 134.1, 133.9, 131.9, 131.2, 129.4, 128.8, 127.6, 124.9, 124.4, 124.2, 
124.1, 80.6, 74.8, 73.9, 39.7, 37.1, 35.7, 28.3, 28.2, 27.9, 26.7, 26.6, 25.7, 22.7, 21.7, 
20.7, 17.6, 17.6, 16.0; HPLC-MS-FIA m/z 638 (M·++18), 621 (M·++1), 603 (M·+–18+1), 
427 (M·-193); []D= +38,6 (c=1, 98% de). 
 (S)-(+)--acetoxy--(phenyl)-acetate of (6S,7R)-6,7-Squalenediol (lower Rf in 
TLC). Rf=0.26; IR 3520, 2965, 2925, 2855, 1750 (CO), 1455, 1375, 1230, 1175, 1055, 
740, 695 cm -1; 1H NMR  7.56-7.44 (2H), 7.43–7.35 (3H), 5.85 (s, 1H), 5.18-5.05 
(5H), 4.85 (dd, J1 = 10 Hz, J2 = 2.5 Hz, 1H), 4.77 (m, 1H), 2.21 (s, 3H), 2.16-1.80 
(18H), 1.68 (bs, 6H), 1.62 (d, J = 1 Hz, 3H), 1.60 (bs, 9H), 1.70-1.20 (4H), 1.35 (s, 3H), 
1.26 (s, 1H), 1.18 (s, 3H); 13C NMR  170.6,168.8, 135.1, 134.9, 133.8, 133.5, 132.1, 
131.2, 129.4, 128.8, 127.6, 124.8, 124.4, 124.2, 124.2, 80.5, 75.0, 74.1, 39.7, 37.5, 35.3, 
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28.2, 28.1, 27.8, 26.7, 26.6, 25.7, 23.3, 22.0, 20.7, 17.7, 16.0, 15.7; HPLC-MS-FIA m/z 
638 (M·++18), 621 (M·++1), 603 (M·+–18 +1), 427 (M·-193); []D= +29.0 (c=1, 98% de). 
 (S)-(+)--acetoxy--(phenyl)-acetate of (10R,11S)-10,11-Squalenediol (higher Rf in 
TLC). Rf=0.40; IR 3530, 2965, 2925, 2855, 1750 (CO), 1455, 1375, 1230, 1180, 1060, 
740, 695 cm -1; 1H NMR  7.55-7.44 (2H), 7.43–7.34 (3H), 5.93 (s, 1H), 5.15-5.03 
(4H), 4.95 (m, 1H), 4.84 (dd, J1 = 9 Hz, J2 = 3.5 Hz, 1H), 2.21 (s, 3H), 2.14-1.76 (18H), 
1.68 (bs, 6H), 1.60 (bs, 9H), 1.56 (bs, 6H), 1.70-1.20 (2H), 1.37 (s, 1H), 1.28-1.13 (3H), 
0.91 (s, 3H); 13C NMR  170.5,168.5, 136.1, 135.6, 134.9, 133.9, 131.5, 131.3, 129.4, 
128.8, 127.6, 124.4, 124.2, 123.9, 123.2, 80.6, 74.8, 73.9, 39.7, 39.7, 37.1, 29.6, 26.7, 
26.6, 26.6, 25.7, 24.4, 22.7, 21.6, 20.8, 17.7, 16.0; HPLC-MS-FIA m/z 638 (M·++18), 
621 (M·++1), 603 (M·+–18 +1), 427 (M·-193); []D= +31.2 (c=1, 98% de). 
(S)-(+)--acetoxy--(phenyl)-acetate of (10S,11R)-10,11-Squalenediol (lower Rf in 
TLC). Rf=0.30; IR 3520, 2965, 2925, 2855, 1750 (CO), 1455, 1375, 1230, 1180, 1060, 
740, 695 cm -1; 1H NMR  7.56-7.44 (2H), 7.43–7.33 (3H), 5.86 (s, 1H), 5.17-5.01 
(4H), 4.95-4.85 (2H), 2.20 (s, 3H), 2.18-1.82 (14H), 1.68 (bs, 6H), 1.62 (d, J = 1 Hz, 
3H), 1.60 (bs, 6H), 1.57 (d, J = 1 Hz, 3H), 1.72-1.20 (2H), 1.27 (d, J = 1 Hz, 3H), 1.18 
(s, 3H); 13C NMR  170.6,168.9, 135.9, 135.7, 134.9, 133.4, 131.4, 131.2, 129.4, 128.8, 
127.6, 124.3, 124.2, 124.1, 122.9, 80.6, 75.0, 74.1, 39.7, 39.6, 37.4, 29.3, 26.7, 26.6, 
26.5, 25.7, 24.0, 23.3, 21.9, 20.7, 17.7, 16.0, 16.0, 15.8; HPLC-MS-FIA m/z 638 
(M·++18), 621 (M·++1), 603 (M·+–18 +1), 427 (M·-193); []D= +36.0 (c=1, 98% de). 
Preparation of Squalenediols by Reduction of Arylacetic Esters. General 
Procedure. A solution of the corresponding arylacetic ester in Et2O, maintained under 
nitrogen atmosphere and at room temperature, was treated with 4.5 molar equiv of 
LiAlH4. The mixture was stirred until the reaction was completed. After the usual 
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workup, the residue was purified by flash chromatography using as eluent 
hexanes:MTBE 85:15 to afford the corresponding enantiomeric diol (87-93% yield). 
Squalene diols reobtained by reduction with LiAlH4 of the corresponding (R)-(-)-MPA 
derivatives showed the following optical rotations: (3S)-2,3-Dihydroxy-2,3-
dihydrosqualene (from higher Rf) []D= -11.8 (c=1, 97% ee); (3R)-2,3-Dihydroxy-
2,3-dihydrosqualene (from lower Rf) []D= +11.4 (c=1, 97% ee); (6R,7S)-6,7-
Dihydroxy-6,7-dihydrosqualene (from higher Rf) []D= -10.0 (c=1, 97% ee); 
(6S,7R)-6,7-Dihydroxy-6,7-dihydrosqualene (from lower Rf) []D= +10.2 (c=1, 97% 
ee); (10R,11S)-10,11-Dihydroxy-10,11-dihydrosqualene (from higher Rf) []D= -6.6 
(c=1, 97% ee); (10S,11R)-10,11-Dihydroxy-10,11-dihydrosqualene (from lower Rf) 
[]D= +6.5 (c=1, 97% ee). These data are in agreement with the previously reported 
optical rotations for these compounds.1
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Figure 1. Arylacetic esters of 2,3- and erythro-6,7- and 10,11-Squalene diols 
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Scheme 1. 1H and 13C NMR Chemical Shift Differences (in ppm) for the Positions Closest 
to the Substituted Carbinolic Center for the Aryl Acetic Esters of the 2,3-Squalene Diol 
Skeleton 
OR
OH
-0.65
-0.65
-0.02
0.60
0.99
0.62
0.87
0.27
0.22
0.06
 = (less polar diastereoisomer)-(more polar diastereoisomer)
OR
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-0.90
0.02
0.00
0.60
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0.10
0.10
0.00
0.10
-0.01
 1H NMR  13C NMR
Plain R= (S)-(+)-9-AMA, italic=(S)-(+)-APA, Bold= (S)-(+)-MPA
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Scheme 2. 1H and 13C NMR Chemical Shift Differences (in ppm) for the Positions Closest 
to the Substituted Carbinolic Center for the Aryl Acetic Esters of the 6,7-erythro-Squalene 
Diol Skeleton 
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Scheme 3. 1H and 13C NMR Chemical Shift Differences (in ppm) for the Positions Closest 
to the Substituted Carbinolic Center for the Aryl Acetic Esters of the 10,11-erythro-
Squalene Diol Skeleton 
Plain R= (S)-(+)-9-AMA, italic=(S)-(+)-APA, Bold= (S)-(+)-MPA
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